Collection: Hepatology

We are dedicated to advancing liver health and hepatology care through our innovative portfolio of therapies and solutions. With a deep understanding of liver diseases and a commitment to improving patient outcomes, we strive to provide comprehensive care for patients affected by hepatological conditions.

Our Hepatology portfolio offers a diverse range of medications, diagnostics, and support services designed to address the unique needs of patients with liver diseases, including viral hepatitis, non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, cirrhosis, and liver cancer. From antiviral medications and liver function tests to advanced imaging technologies and transplant services, we are committed to delivering personalized care that improves liver health and quality of life.

Driven by our passion for innovation and guided by a commitment to excellence, we invest in research and development to bring forward-thinking solutions to the forefront of hepatology practice. From novel therapeutic agents targeting liver fibrosis to innovative approaches for early detection and prevention of liver diseases, we are dedicated to advancing the field of hepatology and improving outcomes for patients with liver conditions.

helcima's Hepatology portfolio reflects our unwavering dedication to quality, safety, and patient-centered care. By collaborating with leading hepatologists, gastroenterologists, transplant surgeons, and liver health advocates, we aim to develop evidence-based treatments and care pathways that optimize liver health, prevent disease progression, and improve overall well-being for patients affected by liver diseases.